86430

Rheumatoid factor; qualitative

The CPT code 86430 represents a laboratory procedure for the qualitative detection of rheumatoid factor (RF) in a patient's serum. Rheumatoid factors are autoantibodies, primarily of the IgM class, that are directed against the Fc portion of IgG antibodies. This test is a crucial diagnostic tool frequently utilized in the evaluation and management of patients presenting with symptoms suggestive of autoimmune and connective tissue disorders, most notably rheumatoid arthritis (RA). The qualitative nature of this assay means that it is designed to determine the simple presence or absence of the rheumatoid factor in the blood sample, rather than quantifying the exact concentration or titer of the autoantibody. A positive qualitative result indicates that the level of rheumatoid factor is above a certain predetermined threshold, suggesting a potential autoimmune process. The procedure begins with the collection of a venous blood sample from the patient using standard phlebotomy techniques. The collected blood is typically drawn into a serum separator tube or a red-top tube without anticoagulant. Following collection, the specimen is centrifuged to separate the serum from the cellular components of the blood. The isolated serum is then subjected to testing using various laboratory methodologies, such as latex agglutination, hemagglutination, or solid-phase immunoassays (like enzyme-linked immunosorbent assay or ELISA), depending on the specific laboratory protocols. In a typical latex agglutination assay, the patient serum is mixed with latex particles that have been coated with human IgG. If rheumatoid factor is present in the serum, it will bind to the IgG on the latex particles, causing visible clumping or agglutination. This agglutination is interpreted as a positive qualitative result. The qualitative test provides a rapid and relatively straightforward initial screening method. It is important to note that while the presence of rheumatoid factor is strongly associated with rheumatoid arthritis, it is not entirely specific to this condition. RF can also be detected in patients with other autoimmune diseases (such as systemic lupus erythematosus, Sjogren's syndrome, and scleroderma), chronic infections (like endocarditis, tuberculosis, and hepatitis C), as well as in a small percentage of healthy individuals, particularly older adults. Therefore, the results of the CPT 86430 qualitative test must always be interpreted in conjunction with a comprehensive clinical evaluation, patient history, physical examination findings, and other relevant diagnostic laboratory tests, including the anti-cyclic citrullinated peptide (anti-CCP) antibody test, to accurately confirm a diagnosis and formulate an appropriate treatment plan.

Clinical Indications

  • Joint pain, swelling, and stiffness, typically symmetric, suggestive of rheumatoid arthritis.
  • Morning stiffness in the joints lasting more than one hour.
  • Evaluation of suspected autoimmune connective tissue diseases, such as Sjogren's syndrome or systemic lupus erythematosus (SLE).
  • Fatigue, unexplained weight loss, and low-grade fever accompanied by polyarthralgia.
  • Assessment of patients with chronic unexplained inflammatory conditions.

Procedure Steps

  1. Patient preparation and verification of the test order.
  2. Venipuncture to collect a whole blood sample into an appropriate tube, such as a serum separator tube or red-top tube.
  3. Transporting the collected blood specimen to the laboratory under proper conditions.
  4. Centrifugation of the blood sample to separate the serum from the cellular components.
  5. Preparation of the testing reagents, which may include IgG-coated latex particles or erythrocytes, depending on the specific assay method.
  6. Mixing an aliquot of the patient's serum with the testing reagent on a test slide or in a well plate.
  7. Observing the mixture for visible signs of macroscopic agglutination or clumping over a specified time period.
  8. Interpreting the results: agglutination indicates a positive qualitative result, while the absence of agglutination indicates a negative result.
  9. Documentation of the qualitative result (positive or negative) in the patient's laboratory report and electronic health record.

Coding Guidelines

  • Report CPT code 86430 when performing a qualitative or screening test for rheumatoid factor.
  • Do not use 86430 if a quantitative rheumatoid factor test is performed; instead, report 86431 (Rheumatoid factor; quantitative).
  • If multiple methods or different types of tests are performed, check the National Correct Coding Initiative (NCCI) edits to ensure proper unbundling rules are followed.
  • Medical necessity must be supported by an appropriate ICD-10-CM diagnosis code representing the patient's signs, symptoms, or condition.
  • CLIA-waived testing facilities should append modifier QW if using an FDA-approved CLIA-waived test system, provided the specific test kit is on the CLIA waived list.

Associated ICD-10 Codes